Your browser doesn't support javascript.
loading
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Brunstein, Claudio G; Pasquini, Marcelo C; Kim, Soyoung; Fei, Mingwei; Adekola, Kehinde; Ahmed, Ibrahim; Aljurf, Mahmoud; Agrawal, Vaibhav; Auletta, Jeffrey J; Battiwalla, Minoo; Bejanyan, Nelli; Bubalo, Joseph; Cerny, Jan; Chee, Lynette; Ciurea, Stefan O; Freytes, Cesar; Gadalla, Shahinaz M; Gale, Robert Peter; Ganguly, Siddhartha; Hashmi, Shahrukh K; Hematti, Peiman; Hildebrandt, Gerhard; Holmberg, Leona A; Lahoud, Oscar B; Landau, Heather; Lazarus, Hillard M; de Lima, Marcos; Mathews, Vikram; Maziarz, Richard; Nishihori, Taiga; Norkin, Maxim; Olsson, Richard; Reshef, Ran; Rotz, Seth; Savani, Bipin; Schouten, Harry C; Seo, Sachiko; Wirk, Baldeep M; Yared, Jean; Mineishi, Shin; Rogosheske, John; Perales, Miguel-Angel.
Afiliación
  • Brunstein CG; Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
  • Pasquini MC; CIBMTR(®) (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: mpasquini@mcw.edu.
  • Kim S; CIBMTR(®) (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Fei M; CIBMTR(®) (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Adekola K; Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Ahmed I; Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Agrawal V; Division of Hematology/Oncology, Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Auletta JJ; Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH, USA.
  • Battiwalla M; Hematology Branch, Sarah Cannon BMT Program, Nashville, TN, USA.
  • Bejanyan N; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Bubalo J; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA, USA.
  • Chee L; The Royal Melbourne Hospital, Melbourne, Australia.
  • Ciurea SO; University of Texas and MD Anderson Cancer Center, Houston, TX, USA.
  • Freytes C; Texas Transplant Institute, San Antonio, TX, USA.
  • Gadalla SM; Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, MD, USA.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS, USA.
  • Hashmi SK; Department of Internal Medicine, Mayo Clinic, MN, USA; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI, USA.
  • Hildebrandt G; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Holmberg LA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Lahoud OB; Bone Marrow Transplant Service, Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Landau H; Bone Marrow Transplant Service, Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lazarus HM; Case Western Reserve University, Cleveland, OH, USA.
  • de Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Mathews V; Department of Hematology, Christian Medical College & Hospital, Vellore, India.
  • Maziarz R; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Norkin M; Division of Hematology/Oncology, University Florida College of Medicine, Gainesville, FL, USA.
  • Olsson R; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Reshef R; Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA.
  • Rotz S; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Savani B; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, Netherlands.
  • Seo S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Wirk BM; Stony Brook University Medical Center, Stony Brook, NY, USA.
  • Yared J; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA.
  • Mineishi S; Penn State Health Hershey Medical Center, Hershey, PA, USA.
  • Rogosheske J; Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
  • Perales MA; Adult Bone Marrow Transplant Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Biol Blood Marrow Transplant ; 25(3): 480-487, 2019 03.
Article en En | MEDLINE | ID: mdl-30423481
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Cálculo de Dosificación de Drogas / Antineoplásicos / Obesidad Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Cálculo de Dosificación de Drogas / Antineoplásicos / Obesidad Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos